Skip to main content

BROWN ADVISORY INC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1345929 BALTIMORE, MD

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,551,880
-$27,400,714 QoQ
Shares Held
34,552
-84.7% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 98.72655707339662.ToString("F0")% Shared 0.ToString("F0")% None 1.2734429266033804.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

BROWN ADVISORY INC holds $557,338,297 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
34,552 $4,551,880

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,551,880 34,552
2025-12-31 $31,952,594 225,288
2025-09-30 $65,774,626 468,547
2025-06-30 $75,315,834 599,219
2025-03-31 $99,046,944 895,542
2024-12-31 $122,616,993 898,293
2024-09-30 $108,554,176 942,147
2024-06-30 $137,011,109 995,214
2024-03-31 $150,102,887 1,088,333
2023-12-31 $146,703,296 1,113,413
2023-09-30 $122,577,974 1,089,582
2023-06-30 $103,716,420 1,099,856
2023-03-31 $109,205,549 1,078,893
2022-12-31 $126,804,789 1,061,661
2022-09-30 $114,167,890 1,074,926
2022-06-30 $104,282,738 1,069,786
2022-03-31 $94,570,311 1,008,750
2021-12-31 $79,760,341 936,484
2021-09-30 $76,057,301 793,007
2021-06-30 $75,748,630 778,346
2021-03-31 $74,343,636 764,459
2020-12-31 $66,877,419 697,730
2020-09-30 $61,844,534 643,142
2020-06-30 $76,303,070 625,435
2020-03-31 $52,317,309 604,475